
Reservoir Neuroscience: A biopharma company innovating novel therapeutic solutions.
Reservoir Neuroscience, founded with a mission to revolutionize neurological health, focuses on developing novel therapeutics aimed at healing the blood-brain barrier. Their innovative approach targets a critical aspect of neurological diseases, aiming to improve patient outcomes significantly. The company's core vision is to transform the treatment landscape for neurological disorders through cutting-edge biopharmaceutical solutions.
Notable figures affiliated with Reservoir Neuroscience include leading scientists and industry experts in neurology and pharmacology. The company has attracted significant interest from prominent investors in the biopharma sector. Key achievements include pioneering research breakthroughs and securing essential patents for their therapeutic technologies. Reservoir Neuroscience's impact lies in its potential to offer groundbreaking treatments for conditions previously deemed untreatable, setting new standards in neurological care.

Empyrean Neuroscience
empyrean.bio

NeuroReserve
neuroreserve.com

Neurovia

NeurAegis
neuraegis.com

NeuroTherapeutics Pharma

NeuroPro Therapeutics

NeuroTherapia
neurotherapia.com

Intellect Neurosciences

Novoron Bioscience
novoron.com

Engrail Therapeutics
engrail.com

Neuraptive Therapeutics
neuraptive.com

Nura Bio
nurabio.com

Regennova
regennova.com

Bolden Therapeutics

Cerebral Therapeutics
Companies similar to Reservoir Neuroscience include Empyrean Neuroscience, NeuroReserve, Neurovia and NeurAegis.
Reservoir Neuroscience was founded in 2019.
Reservoir Neuroscience's headquarters is located in Emeryville, CA, US.
Reservoir Neuroscience's most recent funding round was for $4M (USD) in January 2024.
As of Jan 18, 2024, Reservoir Neuroscience has raised a total of $7.9M (USD).
Reservoir Neuroscience has 8 employees as of Feb 5, 2024.